Riskpilot← Back to searchSign inGet full accessPEROZIN ApS
APSActiveCVR 29183910Danmarksgade 4Manufacture of pharmaceutical preparations · NACE 2120Est. 20053 employeeswww.perozin.com
Revenue 2025
DKK 2,8M
+52% vs 2024
EBITDA margin
69.4%
+31% vs 2024
Equity ratio
66.8%
Financial strength
Net profit 2025
DKK 1M
+39% vs 2024
| Revenue | DKK 2,8M | +52% |
| EBITDA | DKK 1,9M | +31% |
| Net profit | DKK 1M | +39% |
| Total assets | DKK 14,4M | +10% |
| Equity | DKK 9,6M | +12% |
| Employees | 3 | — |
Legal name
PEROZIN ApS
CVR number
29183910
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
1. november 2005
Share capital
DKK 178.572
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er at drive virksomhed med eksport af eget udviklet gigtmiddel.
Address
Danmarksgade 4
Phone
+4520204270
Email
gh@perozin.com
Website
www.perozin.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39 | 164 | 212 | 245 | 566 | 758 | 1.289 | 2.082 | 817 | 950 | 788 | 2.021 | 1.634 | 1.847 | 2.800 |
| Staff expenses | -0 | -0 | -0 | -0 | -371 | -552 | -869 | -834 | -539 | -756 | -254 | -564 | -347 | -363 | -514 |
| EBITDA | 39 | 164 | 212 | 245 | 195 | 206 | 419 | 1.247 | 278 | 194 | 533 | 1.457 | 1.288 | 1.484 | 1.943 |
| Depreciation & amort. | -0 | -0 | -9 | -23 | -32 | -58 | -117 | -114 | -82 | -142 | -47 | -133 | -80 | -248 | -254 |
| EBIT | 39 | 164 | 203 | 221 | 162 | 148 | 302 | 1.133 | 196 | 52 | 486 | 1.324 | 1.208 | 1.235 | 1.688 |
| Net financials | -4 | 1 | 10 | 4 | -6 | -14 | -10 | -18 | -44 | -32 | -10 | -42 | -46 | -110 | -319 |
| Profit before tax | 35 | 165 | 213 | 225 | 156 | 134 | 292 | 1.115 | 152 | 20 | 476 | 1.282 | 1.162 | 1.126 | 1.369 |
| Tax | -0 | -0 | 43 | 54 | 35 | 31 | 66 | 247 | 34 | 6 | 105 | 283 | 257 | 389 | 343 |
| Net profit | 35 | 165 | 169 | 171 | 121 | 103 | 226 | 868 | 118 | 14 | 371 | 1.000 | 904 | 736 | 1.026 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 275 | 556 | 593 | 803 | 861 | 1.012 | 5.520 | 6.281 | 6.146 | 5.861 | 6.323 | 7.485 | 8.506 | 13.166 | 14.440 |
| Equity | 144 | 310 | 479 | 552 | 573 | 676 | 4.607 | 5.475 | 5.593 | 5.607 | 5.978 | 6.978 | 7.882 | 8.618 | 9.644 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 98 | 296 | 261 | 1.338 | 1.155 |
| Short-term debt | 131 | 246 | 114 | 247 | 281 | 314 | 897 | 796 | 545 | 240 | 234 | 211 | 363 | 3.026 | 3.405 |
| Total debt | 131 | 246 | 114 | 247 | 281 | 314 | 897 | 796 | 545 | 240 | 331 | 507 | 624 | 4.365 | 4.560 |
EBITDA margin
69.4%
This company
15.8%
Market median
+339% vs market
20122025
Equity ratio
66.8%
This company
38.2%
Market median
+75% vs market
20122025
Return on equity
10.6%
This company
18.4%
Market median
+42% vs market
20122025
Net profit margin
36.7%
This company
8.1%
Market median
+353% vs market
20122025
Asset turnover
0.19×
This company
1.12×
Market median
-83% vs market
20122025
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-05-01 – 2019-12-31
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via CVR / Virk · Period 2015-05-01 – 2016-04-30
- Annual report 2015Filed via CVR / Virk · Period 2014-05-01 – 2015-04-30
- Annual report 2014Filed via CVR / Virk · Period 2013-05-01 – 2014-04-30
- Annual report 2013Filed via CVR / Virk · Period 2012-05-01 – 2013-04-30
- Annual report 2012Filed via CVR / Virk · Period 2011-05-01 – 2012-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
GG Management | Management | 2005 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
GEBAL Holding ApS | Company | 66.7% | 66.7% | 2018 |
| Individual | 15.0% | 15.0% | 2018 | |
| Individual | 15.0% | 15.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GEBAL Holding ApS
PEROZIN ApS Board members of PEROZIN ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gerard Gerner Hansen | Management | 0 companies |